mitomycin has been researched along with picibanil in 107 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 61 (57.01) | 18.7374 |
1990's | 37 (34.58) | 18.2507 |
2000's | 8 (7.48) | 29.6817 |
2010's | 1 (0.93) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, DB; Kuo, SH; Lee, LN; Luh, KT; Yang, PC; Yu, CJ | 1 |
Kim, JP; Kwon, OJ; Oh, ST; Yang, HK | 1 |
Furukawa, H; Hara, T; Taniguchi, T | 2 |
Azuma, S; Furuta, T; Kaneda, N; Kanno, A; Katou, M; Miya, K; Saji, S; Takao, H; Umemoto, T; Yamawaki, Y | 1 |
Hori, T; Kan, N; Kato, H; Kodama, H; Kudo, N; Mukaihara, S; Ogawa, H; Ohsumi, K; Takenaka, A; Yasumura, T | 1 |
Azuma, S; Furuta, T; Kanno, A; Kato, M; Miya, K; Saji, S; Sugiyama, Y; Takao, H; Umemoto, T | 1 |
Akagi, M; Kakegawa, T; Maehara, Y; Shimazu, H; Sugimachi, K; Tomita, M | 1 |
Hiraoka, T; Miyauchi, Y; Mizutani, J; Yamashita, R | 1 |
Abe, R; Akiyoshi, T; Arinaga, S; Inoue, H; Karimine, N; Matsuoka, H; Nanbara, S; Takamuku, K; Ueo, H; Watanabe, D | 1 |
Fujii, S; Iwamoto, S; Kotake, H; Mashiba, H; Murai, N; Okuno, F; Sawada, Y; Yurino, N | 1 |
Hioki, K; Hiramatsu, Y; Kitade, H; Nakagawa, A; Ogura, T; Takada, H; Yamamoto, M; Yoshioka, K | 1 |
Ryoyama, C; Ryoyama, K | 2 |
Fujii, T; Yokomori, T | 1 |
Niitsu, Y; Saito, K; Sato, M; Takagane, A; Terashima, M; Yokkaichi, H | 1 |
Inokuchi, K; Kano, T; Kawami, H; Kohdono, S; Oka, N | 1 |
Goshima, H; Ishida, N; Itou, F; Kokehara, N; Matsumoto, M; Oota, M; Yamazaki, Y | 1 |
Abe, O; Hattori, T; Kikuchi, K; Komi, N; Kondo, T; Nakajima, T; Nakazato, H; Sugimachi, K; Taguchi, T; Tanabe, T | 1 |
Azuma, S; Furuta, T; Kunieda, K; Miya, K; Saji, S; Sugiyama, Y; Takao, H; Tanemura, H; Yoshida, A | 1 |
Anai, H; Korenaga, D; Maehara, Y; Ohi, Y; Okada, Y; Okubo, K; Sugimachi, K | 1 |
Kawahara, T; Kikkawa, N; Tsuchiya, Y | 1 |
Ichihashi, H; Imaizumi, M; Kamei, H; Kondo, T | 2 |
Ito, T; Kinashi, N; Yakabe, A; Yamashita, S | 1 |
Aoki, Y; Asae, M; Ichimiya, G; Imai, T; Kakihara, M; Kashitani, M; Katsumi, M; Ooshima, K; Tabuse, Y; Tanimura, H | 1 |
Abe, O; Hattori, T; Kikuchi, K; Komi, N; Kondo, T; Kunii, Y; Nakajima, T; Nakazato, H; Taguchi, T; Tanabe, T | 1 |
Abe, O; Hattori, T; Inokuchi, K; Inoue, K; Kikuchi, K; Kondou, T; Nakajima, T; Ogawa, N; Taguchi, T; Tanabe, T | 1 |
Nomura, S; Saito, K; Takahashi, T | 1 |
Hamada, H; Mori, N; Nakajima, I; Nakamura, T; Nakamura, Y; Tanaka, A; Wada, T; Yasutomi, M | 1 |
Iga, C; Kawashima, Y; Nishimura, J; Okajima, K; Sakuramoto, K; Toyoda, M | 1 |
Ebina, T; Ishida, N; Kohya, H; Yamaguchi, T | 1 |
Fujise, K; Hasumura, S; Homma, S; Kameda, H; Matsuura, T; Nagamori, S; Niiya, M; Shimizu, K; Sujino, H | 1 |
Itoh, T; Komatsu, Y; Saitoh, S; Sakata, Y; Sasaki, D; Suzuki, H; Takagi, S; Tsushima, K; Yoshida, Y | 1 |
Hara, Y; Hirai, K; Hirayama, C; Horie, Y; Inoue, J; Kubo, Y; Ogawa, N; Okumura, M; Shimizu, M; Tanikawa, K | 1 |
Akiyoshi, T; Arinaga, S; Tsuji, H | 1 |
Hashizume, Y; Ichihashi, T; Iida, S; Kimoto, H; Kobayashi, H; Sato, H; Shimizu, J; Tsunamura, Y; Watanabe, Y; Yamada, T | 1 |
Fujitomi, Y; Ichimanda, M; Mori, Y; Oka, K; Shibata, O; Shigemitsu, O; Shirabe, J; Takasaki, H; Uchida, Y | 1 |
Hidaka, H; Ikeda, K; Inoue, H; Kajiya, Y; Kobayashi, H | 1 |
Itoh, H; Kitajima, M; Seki, M; Tachikawa, I; Watanabe, Y; Yagita, A | 1 |
Hosaka, N; Itoh, H; Matsumoto, H; Oda, T; Okada, N; Ono, M; Ootsuka, S; Orima, I; Takeuchi, N; Yagita, A | 1 |
Kim, JP | 2 |
Nakajima, T; Nishi, M; Ohta, H | 1 |
Awane, Y; Ishibiki, H; Kamei, H; Nakajima, T; Nomoto, K; Sekiguchi, M; Tamada, R; Toge, T; Tsuru, S | 1 |
Kato, T; Kito, T; Miyaishi, S; Morimoto, T; Nakazato, H; Nishimura, M; Sakamoto, J; Yamamura, Y; Yasue, M; Yasui, K | 1 |
Tamada, R | 1 |
Yasutomi, M | 1 |
Nagai, K; Suda, T | 1 |
Abe, O; Hattori, T; Inokuchi, K; Inoue, K; Kikuchi, K; Kondo, T; Nakajima, T; Taguchi, T; Tamada, R; Tanabe, T | 1 |
Abe, T; Horiike, S; Inazawa, J; Misawa, S; Nishigaki, H; Okuda, T; Taniwaki, M; Tsuji, H; Yashige, H; Yokota, S | 1 |
Abe, T; Horiike, S; Misawa, S; Nishigaki, H; Takeda, S; Takino, T; Taniwaki, M; Tsuda, S; Tsuji, T; Yashige, H | 1 |
Haranaka, K; Haranaka, R; Hasegawa, R; Nakagawa, S; Sakurai, A; Satomi, N | 1 |
Baba, T; Furukohori, N; Itoh, T; Kawata, K; Kimura, T; Munakata, A; Saitoh, S; Sakata, Y; Suzuki, H; Tamura, Y | 1 |
Hatano, K; Hattori, H; Mamiya, T; Mikuriya, S; Shiina, T; Yamada, T | 1 |
Fukushi, G; Itoh, T; Kimura, M; Kimura, T; Kishibe, T; Saitoh, S; Sakata, Y; Suzuki, H; Tamura, Y; Tsushima, K | 1 |
Hatano, T; Hayakawa, M; Igarashi, M; Kashiwabara, N; Koyama, Y; Miyazato, T; Osawa, A; Saito, S; Sato, K | 1 |
Ariga, T; Kikuchi, T; Koh, Z; Mukai, M; Nagao, K; Nagashima, T; Odaka, M; Ryu, S; Satoh, H; Yamazaki, Y | 1 |
Endoh, F; Fujimoto, S; Kawata, S; Kurihara, M; Miyazaki, M; Ohta, M; Shimura, T; Sugasawa, H; Takahashi, O; Udagawa, I | 1 |
Jo, T | 1 |
Abe, O; Hattori, T; Inokuchi, K; Inoue, K; Kikuchi, K; Kondo, T; Nakajima, T; Ogawa, N; Taguchi, T; Tanabe, T | 1 |
Akimoto, R; Asano, E; Higashino, Y; Kato, M; Mukawa, A; Nagakawa, T; Nakamura, T; Uchida, H | 1 |
Hatsuse, K; Hiraide, H; Kadota, T; Kanabe, S; Kawano, M; Kurokawa, T; Mimura, K; Mochizuki, H; Tamaki, K; Tamakuma, S | 1 |
Sawaki, S; Tsukuda, M | 1 |
Akiharu, W; Fujiwara, M; Higashi, T; Ito, T; Kobayashi, M; Nagashima, H; Nakatsukasa, H; Shiota, T; Yamamoto, H; Yamauchi, Y | 1 |
Ban, Y; Fujihiro, S; Fujimoto, Y; Horie, M; Kanematsu, M; Kuriyama, M; Nishiura, T; Okano, M; Takeuchi, T | 1 |
Fukuoka, M; Matsui, K; Negoro, S; Ryu, S; Sakaguchi, K; Sakai, N; Takada, M; Tamai, S | 1 |
Kaneto, E; Kurimura, O; Kurimura, T; Sasaki, H; Tamura, I | 1 |
Takada, M | 1 |
Nishimura, M; Ota, K; Urata, A | 1 |
Kito, T; Nakazato, H; Yamada, E; Yamamura, Y; Yasue, M | 1 |
Gose, K; Imajo, Y; Imanaka, K; Kimura, S; Maeda, T; Morita, M; Ogawa, Y; Yamamoto, Y; Yoshida, S | 1 |
Micksche, M; Uchida, A | 1 |
Hattori, T; Hirono, M; Nakagami, K; Niimoto, M; Oride, M | 1 |
Hamazoe, R; Kanayama, H; Karino, T; Koga, S; Maeta, M; Oda, M; Osaki, Y; Shimizu, N; Yamane, T | 1 |
Izumi, T; Kurihara, M; Maruyama, T; Miyasaka, K; Sasaki, Y | 1 |
Nakazato, H | 1 |
Amano, H; Hiura, T; Mukai, M; Nagao, K; Nakajima, K; Namiki, S; Oda, S; Yamazaki, Y | 1 |
Izumi, T; Kurihara, M; Maruyama, T; Sasaki, Y; Shirakabe, H | 1 |
Kikuchi, K; Komatsu, Y; Nishimura, S; Sakata, Y; Sugawara, K; Yoshida, Y | 1 |
Nishimura, T; Okamura, H; Satoh, S; Suzuki, A | 1 |
Den, N; Mukai, M; Nagao, K; Namiki, S; Oda, S; Yamazaki, Y | 1 |
Hiura, T; Mukai, M; Nagao, K; Namiki, S; Yamazaki, Y | 1 |
Kudo, C; Saito, M; Yoshida, T | 1 |
Akiyama, T; Kiriyama, M; Kita, I; Kosaka, T; Kurosaka, Y; Matsushita, M; Takashima, S; Tomita, F | 1 |
Fuchimoto, S; Gouchi, A; Konaga, E; Mannami, T; Ohara, T; Okamura, S; Orita, K; Sato, K; Tanaka, N | 1 |
Baba, H; Furusawa, M; Kakeji, Y; Maehara, Y; Okuyama, T; Sugimachi, K | 1 |
Aoyagi, K; Kawabata, S; Kodama, I; Koufuji, K; Kumegawa, H; Maruiwa, M; Ohta, J; Suematsu, T; Tanaka, T; Tsuji, Y | 1 |
Aoyagi, K; Kakegawa, T; Kodama, I; Kofuji, K; Kumegawa, H; Maruiwa, M; Ohta, J; Takeda, J; Tanaka, T | 1 |
Azuma, S; Furuta, T; Kato, M; Kida, H; Kunieda, K; Miya, K; Saji, S; Sugiyama, Y; Takao, H; Umemoto, T | 1 |
Furukawa, T; Hoffman, RM; Kitajima, M; Kubota, T; Kuo, TH; Watanabe, M | 1 |
Fujisawa, J; Kondo, Y; Miyakawa, K; Nakanishi, Y; Nishimura, A; Oku, T; Osawa, S; Shiroto, H; Uchino, J | 1 |
Fukushima, H; Kobayashi, E; Koezuka, Y; Motoki, K; Uchida, T | 1 |
Aichi, A; Funaki, M; Hiden, A; Iwakaki, H; Kamikawa, Y; Nagata, H; Oda, S; Okabayashi, T; Tanaka, N | 1 |
Kajiura, Y; Kondoh, Y; Makuuchi, H; Mitomi, T; Miyaji, M; Nakamura, K; Ogoshi, K; Tajima, T | 1 |
Arai, H; Fujimaki, M; Katsuyama, S; Masuyama, K; Minamimura, T; Okamoto, M; Ookami, H; Sakamoto, T; Takemori, S; Tazawa, K; Yamamoto, K; Yamasaki, K | 1 |
Cho, KS; Choi, YM; Kim, SY; Park, HC; Yoon, C; Yoon, HJ | 1 |
Fukumoto, M; Hayashi, H; Imai, S; Kawabata, K; Mizuta, J; Nagami, H; Nakagawa, M; Nio, M; Nio, Y; Sato, M; Shiraishi, T; Tamura, K; Tsubono, M; Tsuchitani, T | 1 |
Aoyagi, K; Koufuji, K; Murakami, N; Shirouzu, K; Takeda, J; Terasaki, Y; Yamasaki, Y; Yano, S | 1 |
Fujimoto, T; Mai, M; Minami, S; Takahashi, Y; Wang, X; Zhang, B | 1 |
Cho, YK; Choi, JH; Joo, HJ; Kim, HC; Kim, HS; Kim, MW; Lee, KB; Lim, HY; Yi, JW | 1 |
Andou, K; Fujisaki, S; Fukuzawa, M; Nezu, T; Shibata, M; Tomita, R | 1 |
Hojyo, K; Isomoto, H; Kato, T; Kodaira, S; Kunii, Y; Kunitomo, K; Niimoto, M; Nishida, O; Ohashi, Y; Takahashi, T; Tominaga, T; Watanabe, M; Yasutomi, M | 1 |
Maataoui, A; Ni, L; Oppermann, E; Qian, J; Vogl, TJ; Vossoughi, D | 1 |
Hamada, T; Ichimura, W; Minagawa, N; Mino, K; Naito, H; Orimo, T; Shibazaki, W; Shinohara, T | 1 |
Nagaie, T; Shirabe, K; Wakiyama, S | 1 |
Fujita, M; Matsuura, O; Morohashi, H; Morohashi, S; Nishimura, A; Yakoshi, Y; Yamada, K; Yonaiyama, S | 1 |
1 review(s) available for mitomycin and picibanil
Article | Year |
---|---|
Clinical potential of biological response modifiers combined with chemotherapy for gastric cancer. Japanese experience.
Topics: Adjuvants, Immunologic; Antibiotics, Antineoplastic; Antineoplastic Agents; Chemotherapy, Adjuvant; Humans; Immunologic Factors; Mitomycin; Picibanil; Proteoglycans; Splenectomy; Stomach Neoplasms | 2002 |
34 trial(s) available for mitomycin and picibanil
Article | Year |
---|---|
Comparison of OK-432 and mitomycin C pleurodesis for malignant pleural effusion caused by lung cancer. A randomized trial.
Topics: Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Humans; Immunity, Cellular; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Picibanil; Pleural Effusion; Prospective Studies; Tissue Adhesions | 1992 |
Results of surgery on 6589 gastric cancer patients and immunochemosurgery as the best treatment of advanced gastric cancer.
Topics: Anastomosis, Surgical; Antibody-Dependent Cell Cytotoxicity; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Fluorouracil; Gastrectomy; Humans; Immunotherapy; Jejunostomy; Leukocyte Count; Male; Middle Aged; Mitomycin; Neoplasm Staging; Picibanil; Prognosis; Skin Tests; Stomach Neoplasms; Survival Rate; T-Lymphocytes | 1992 |
[Intrapleural treatment of breast cancer patients with pleural effusions: an analysis of 13 institutes in Kyoto and Shiga Prefectures. Kyoto and Shiga Breast Cancer Study Group].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Cytarabine; Doxorubicin; Drainage; Female; Humans; Immunotherapy, Adoptive; Lymphatic Metastasis; Lymphocytes, Tumor-Infiltrating; Middle Aged; Mitomycin; Multivariate Analysis; Picibanil; Pleural Effusion; Prognosis; Proportional Hazards Models; Retrospective Studies; Survival Rate | 1992 |
Early postoperative chemotherapy following noncurative resection for patients with advanced gastric cancer.
Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Fluorouracil; Humans; Male; Middle Aged; Mitomycin; Picibanil; Prospective Studies; Proteoglycans; Stomach Neoplasms; Tegafur; Uracil | 1992 |
A trial of adjuvant chemoimmunotherapy with mitomycin C and OK-432 for stage III gastric carcinoma.
Topics: Carcinoma; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Mitomycin; Picibanil; Stomach Neoplasms; Survival Rate | 1992 |
Postoperative adjuvant immunochemotherapy with mitomycin C, tegafur, PSK and/or OK-432 for gastric cancer, with special reference to the change in stimulation index after gastrectomy.
Topics: Adjuvants, Immunologic; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Female; Gastrectomy; Humans; Lymphocyte Activation; Male; Middle Aged; Mitomycin; Mitomycins; Multicenter Studies as Topic; Picibanil; Postoperative Care; Prospective Studies; Proteoglycans; Randomized Controlled Trials as Topic; Stomach Neoplasms; Survival Rate; Tegafur | 1990 |
[Cooperative study on surgical adjuvant immunochemotherapy for prevention of postoperative recurrence of gastric cancer (II). Cooperative study group on surgical adjuvant immunochemotherapy for prevention of postoperative recurrence of gastric cancer supp
Topics: Adjuvants, Immunologic; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Fluorouracil; Gastrectomy; Humans; Japan; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Picibanil; Prognosis; Proportional Hazards Models; Prospective Studies; Proteoglycans; Stomach Neoplasms; Survival Rate | 1990 |
[Clinical effect of combined chemotherapy with UFT, MMC and OK-432 in recurring or advanced cancer of the digestive organs].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Digestive System Neoplasms; Drug Evaluation; Female; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Multicenter Studies as Topic; Neoplasm Metastasis; Neoplasm Recurrence, Local; Picibanil; Remission Induction; Tegafur; Uracil | 1989 |
[Adjuvant chemotherapy for gastric cancer--the third study. First report: central randomization by telephone method and analysis of patients' background factors].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Drug Administration Schedule; Fluorouracil; Humans; Japan; Mitomycin; Mitomycins; Multicenter Studies as Topic; Picibanil; Random Allocation; Stomach Neoplasms; Tegafur; Telephone | 1989 |
[Multi-institutional cooperative study of adjuvant immunochemotherapy in gastric cancer--five-year survival rate].
Topics: Adjuvants, Immunologic; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; Gastrectomy; Humans; Japan; Male; Mitomycin; Mitomycins; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Picibanil; Proteoglycans; Stomach Neoplasms; Tegafur | 1989 |
Randomized controlled study of mitomycin C/carboquone/5-fluorouracil/OK-432 (MQ-F-OK) therapy and mitomycin C/5-fluorouracil/doxorubicin (FAM) therapy against advanced liver cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Clinical Trials as Topic; Doxorubicin; Female; Fluorouracil; Humans; Liver Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Picibanil; Random Allocation | 1989 |
[Clinical value of OK-432 immunotherapy after one-shot arterial infusion of anti-cancer agents in the treatment of hepatocellular carcinoma--a randomized study].
Topics: Administration, Oral; Biological Products; Carcinoma, Hepatocellular; Clinical Trials as Topic; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Mitomycin; Mitomycins; Picibanil; Random Allocation; Tegafur | 1988 |
[Clinical value of postoperative chemotherapy for non-small cell lung cancer--with special reference to long-term combined chemotherapy combined with immunotherapy].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biological Products; Carbazilquinone; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Nimustine; Nitrosourea Compounds; Picibanil; Pneumonectomy; Postoperative Care; Random Allocation | 1985 |
Immunochemosurgery as a new approach to reasonable treatment of advanced cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Biological Products; Clinical Trials as Topic; Combined Modality Therapy; Cytarabine; Female; Fluorouracil; Follow-Up Studies; Gastrectomy; Humans; Korea; Male; Middle Aged; Mitomycin; Mitomycins; Picibanil; Random Allocation; Semustine; Stomach Neoplasms; T-Lymphocytes; Time Factors | 1988 |
[Changes in nonspecific suppressor factors in the serum of gastric cancer patients after surgery and immunochemotherapy].
Topics: Female; Humans; Lymphatic Metastasis; Lymphocyte Activation; Male; Middle Aged; Mitomycin; Mitomycins; Picibanil; Postoperative Period; Proteoglycans; Random Allocation; Stomach Neoplasms; Suppressor Factors, Immunologic; Tegafur | 1986 |
[A randomized controlled trial of surgical adjuvant therapy with mitomycin C, 5-fluorouracil and OK-432 in patients with gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biological Products; Combined Modality Therapy; Female; Fluorouracil; Gastrectomy; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Mitomycins; Picibanil; Postoperative Period; Random Allocation; Stomach Neoplasms | 1986 |
[Surgery and adjuvant therapy of gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Humans; Lymph Node Excision; Mitomycin; Mitomycins; Picibanil; Postoperative Care; Proteoglycans; Stomach Neoplasms; Tegafur | 1986 |
[A multi-institutional study on postoperative adjuvant immunochemotherapy of gastric cancer (II)].
Topics: Biological Products; Drug Therapy, Combination; Humans; Mitomycin; Mitomycins; Picibanil; Postoperative Care; Proteoglycans; Stomach Neoplasms; Tegafur | 1987 |
[Controlled study of MQF-OK therapy with FT and with UFT on various advanced gastrointestinal cancers. Hirosaki Cooperative Study Group of Cancer Chemotherapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Clinical Trials as Topic; Double-Blind Method; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Picibanil; Remission Induction; Stomach Neoplasms; Tegafur; Uracil | 1988 |
[Studies on the effects of adjuvant chemotherapy on the survival period of patients with colorectal carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Combined Modality Therapy; Doxorubicin; Female; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Picibanil; Prospective Studies; Rectal Neoplasms; Tegafur | 1985 |
[A multi-institutional study on postoperative adjuvant immunochemotherapy of gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biological Products; Humans; Mitomycin; Mitomycins; Multi-Institutional Systems; Picibanil; Postoperative Care; Proteoglycans; Stomach Neoplasms; Tegafur | 1985 |
[Comparison of immunochemotherapy and chemotherapy of stage IV gastric carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biological Products; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Picibanil; Proteoglycans; Random Allocation; Stomach Neoplasms; Tegafur | 1985 |
[Local application of anti-cancer drugs for the treatment of malignant pleural and pericardial effusion].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Bleomycin; Carcinoma, Squamous Cell; Cell Wall; Doxorubicin; Drainage; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Nimustine; Nitrosourea Compounds; Nocardia; Pericardial Effusion; Picibanil; Pleural Effusion; Random Allocation | 1984 |
[Randomized controlled study of OK-432 in the treatment of cancerous pleurisy].
Topics: Adult; Aged; Biological Products; Clinical Trials as Topic; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Picibanil; Pleural Neoplasms; Pleurisy; Random Allocation | 1983 |
[Adjuvant immunochemotherapy combined with OK-432 following surgery of stomach cancer].
Topics: Aged; Biological Products; Drug Therapy, Combination; Female; Fluorouracil; Humans; Immunotherapy; Male; Middle Aged; Mitomycin; Mitomycins; Picibanil; Stomach Neoplasms | 1983 |
[Cooperative studies on surgical adjuvant immunochemotherapy for prevention of postoperative recurrence of gastric cancer].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Female; Fluorouracil; Gastrectomy; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Picibanil; Postoperative Care; Proteoglycans; Stomach Neoplasms | 1984 |
[Immunological approach and surgical treatment of cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Fluorouracil; Gastrectomy; Humans; Mitomycin; Mitomycins; Picibanil; Prospective Studies; Stomach Neoplasms; Tegafur | 1983 |
Intratumoral injection of a streptococcal preparation, OK-432, before surgery for gastric cancer. A randomized trial. Cooperative Study Group of Preoperative Intratumoral Immunotherapy for Cancer.
Topics: Adjuvants, Immunologic; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Injections; Male; Middle Aged; Mitomycin; Neoplasm Staging; Picibanil; Premedication; Stomach Neoplasms; Survival Rate; Tegafur | 1994 |
Postoperative immunochemotherapy including streptococcal lysate OK-432 is effective for patients with gastric cancer and serosal invasion.
Topics: Adjuvants, Immunologic; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Administration Schedule; Female; Gastrectomy; Humans; Injections, Intradermal; Injections, Intraperitoneal; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Neoplasm Staging; Peritoneal Neoplasms; Picibanil; Postoperative Care; Prognosis; Prospective Studies; Stomach Neoplasms; Survival Rate; Tegafur; Treatment Outcome; Uracil | 1994 |
[Randomized controlled study on adjuvant immunochemotherapy with carmofur (HCFU) for noncuratively resected and unresected gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Chi-Square Distribution; Combined Modality Therapy; Fluorouracil; Follow-Up Studies; Humans; Immunotherapy; Japan; Mitomycin; Picibanil; Stomach Neoplasms | 1996 |
[Preoperative intra tumor biological response modifier injection therapy for patients with stomach neoplasms].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Humans; Immunologic Factors; Injections, Intralesional; Mitomycin; Picibanil; Preoperative Care; Stomach Neoplasms; Tegafur | 1995 |
OK-432 and 5-fluorouracil, doxorubicin, and mitomycin C (FAM-P) versus FAM chemotherapy in patients with curatively resected gastric carcinoma: a randomized Phase III trial.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Female; Fluorouracil; Humans; Immunotherapy; Male; Middle Aged; Mitomycin; Picibanil; Stomach Neoplasms | 1998 |
Multi-institutional randomized clinical study on the comparative effects of intracavital chemotherapy alone versus immunotherapy alone versus immunochemotherapy for malignant effusion.
Topics: Adjuvants, Immunologic; Aged; Antineoplastic Combined Chemotherapy Protocols; Ascitic Fluid; Cisplatin; Combined Modality Therapy; Cytokines; Digestive System Neoplasms; Doxorubicin; Female; Humans; Injections, Intralesional; Lung Neoplasms; Male; Middle Aged; Mitomycin; Patient Selection; Picibanil; Pleural Effusion, Malignant; Prospective Studies | 1999 |
Randomized controlled trial of the efficacy of adjuvant immunochemotherapy and adjuvant chemotherapy for colorectal cancer, using different combinations of the intracutaneous streptococcal preparation OK-432 and the oral pyrimidines 1-hexylcarbamoyl-5-flu
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colectomy; Colonic Neoplasms; Drug Combinations; Female; Fluorouracil; Humans; Injections, Subcutaneous; Male; Middle Aged; Mitomycin; Neoplasm Staging; Picibanil; Pyrimidines; Radiotherapy, Adjuvant; Rectal Neoplasms; Survival Analysis; Tegafur; Treatment Outcome; Uracil | 2004 |
72 other study(ies) available for mitomycin and picibanil
Article | Year |
---|---|
[Comparative changes in hepatic function induced by transhepatic arterial chemoimmunoembolization among liver cancer patients].
Topics: Chemoembolization, Therapeutic; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver; Liver Cirrhosis; Liver Neoplasms; Mitomycin; Picibanil | 1992 |
[Significance of antitumor effects and immunological response on endogenously induced LAK therapy for primary or metastatic liver tumor].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Doxorubicin; Drug Administration Schedule; Humans; Interleukin-2; Killer Cells, Lymphokine-Activated; Killer Cells, Natural; Liver Neoplasms; Mitomycin; Picibanil; Stomach Neoplasms; Survival Rate | 1992 |
[Clinical studies on locoregional immunochemotherapy of peritonitis carcinomatosa].
Topics: Cisplatin; Humans; Immunotherapy; Infusions, Parenteral; Mitomycin; Pancreatic Neoplasms; Peritonitis; Picibanil; Stomach Neoplasms | 1992 |
Promotion of hepatic metastases by liver resection in the rat.
Topics: Animals; Fluorouracil; Liver; Liver Neoplasms; Liver Neoplasms, Experimental; Liver Regeneration; Mitomycin; Neoplasm Metastasis; Picibanil; Rats; Rats, Inbred Strains | 1992 |
[Rupture of hepatocellular carcinoma with multiple pulmonary metastasis successfully treated by transcatheter arterial embolization (TAE) of tumor: a case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Doxorubicin; Female; Hepatic Artery; Humans; Iodized Oil; Liver Neoplasms; Lung Neoplasms; Mitomycin; Picibanil; Prognosis; Remission Induction; Rupture, Spontaneous; Tegafur; Uracil | 1991 |
[Complete response in a case of rectal carcinoma with multiple liver metastasis treated by infuse-a-port].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Hepatic Artery; Humans; Infusion Pumps; Infusions, Intra-Arterial; Injections, Subcutaneous; Liver Neoplasms; Mitomycin; Picibanil; Rectal Neoplasms; Tegafur | 1991 |
Cyclophosphamide modifies the induction kinetics but not cell types and cytotoxic mechanisms of antitumor cells elicited with OK-432 plus attenuated tumor cells.
Topics: Animals; Arachidonic Acid; Cell Cycle; Cell Division; Cyclophosphamide; Exudates and Transudates; Kinetics; Leukemia L1210; Lipopolysaccharides; Macrophages; Male; Mice; Mice, Inbred C57BL; Mitomycin; Neoplasms, Experimental; Peritoneal Cavity; Picibanil; Spleen; Toxins, Biological; Tumor Cells, Cultured | 1991 |
[A clinical study of vitamin A concerning auxiliary chemotherapies after operation of gastric cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Gastrectomy; Humans; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasm Metastasis; Picibanil; Postoperative Care; Stomach Neoplasms; Survival Rate; Tegafur; Vitamin A | 1991 |
[A case of inoperable advanced gastric cancer with effective treatment by local administration of OK-432, intra-abdominal administration of CDDP, and long-term high-dose mitomycin C, and UFT].
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Humans; Infusions, Parenteral; Injections, Intralesional; Male; Middle Aged; Mitomycin; Mitomycins; Picibanil; Remission Induction; Stomach Neoplasms; Tegafur; Uracil | 1991 |
[Intraperitoneal administration of cis-platin with arterial infusion chemotherapy of advanced and recurrent gastric cancer].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Infusions, Parenteral; Male; Middle Aged; Mitomycin; Mitomycins; Picibanil; Stomach Neoplasms | 1991 |
[Intraoperative intraperitoneal administration of CDDP against gastric cancer with peritoneal dissemination].
Topics: Adult; Aged; Ascitic Fluid; Cisplatin; Female; Gastrectomy; Humans; Intraoperative Care; Male; Middle Aged; Mitomycin; Mitomycins; Peritoneal Cavity; Picibanil; Stomach Neoplasms; Survival Rate | 1990 |
[A case of unresectable liver metastasis from leiomyosarcoma of the stomach successfully treated by intra hepato-arterial chemotherapy with Infuse-A-Port].
Topics: Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Fluorouracil; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Leiomyosarcoma; Liver Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Picibanil; Stomach Neoplasms | 1990 |
[Intraoperative intraperitoneal administration of mitomycin C and OK-432 for peritoneal dissemination of gastric cancer].
Topics: Adult; Aged; Biological Products; Female; Gastrectomy; Humans; Infusions, Parenteral; Intraoperative Care; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasm Seeding; Peritoneal Neoplasms; Picibanil; Prognosis; Stomach Neoplasms; Survival Rate | 1990 |
[A case report of hemolytic uremic syndrome (HUS) induced by antineoplastic agents].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Hemolytic-Uremic Syndrome; Humans; Mitomycin; Mitomycins; Picibanil; Proteoglycans; Stomach Neoplasms; Tegafur; Uracil | 1990 |
[Hepatic resection plus hepatic artery infusion with implantable port for colorectal metastases].
Topics: Antineoplastic Agents; Colorectal Neoplasms; Combined Modality Therapy; Doxorubicin; Female; Hepatectomy; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Middle Aged; Mitomycin; Mitomycins; Picibanil; Survival Rate | 1990 |
[Local injection of OK-432 and mitomycin C into vulvar cancer responding poorly to bleomycin and linac irradiation].
Topics: Aged; Biological Products; Bleomycin; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Humans; Instillation, Drug; Mitomycin; Mitomycins; Picibanil; Vulvar Neoplasms | 1987 |
Augmented induction of antitumor cells in vivo by cyclophosphamide fails to benefit antitumor resistance of the host.
Topics: Animals; Cyclophosphamide; Dose-Response Relationship, Drug; Immunity, Cellular; Immunotherapy; In Vitro Techniques; Mice; Mice, Inbred C57BL; Mitomycin; Mitomycins; Picibanil; Thymoma; Thymus Neoplasms; Tumor Cells, Cultured | 1989 |
[A case report of retrovesical tumor effectively responsive to chemotherapy].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Humans; Male; Mitomycin; Mitomycins; Neoplasm Staging; Picibanil; Tegafur; Urinary Bladder Neoplasms | 1989 |
[Three cases of effective hepatic arterial infusion with OK-432, mitomycin C and 5-fluorouracil in liver metastasis from gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Picibanil; Remission Induction; Stomach Neoplasms | 1989 |
[A case of advanced gastric cancer with Virchow's node metastasis, responding to concomitant plasma exchange and immunochemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Biological Products; Combined Modality Therapy; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Mitomycins; Neck; Picibanil; Plasma Exchange; Remission Induction; Stomach Neoplasms; Tegafur | 1989 |
The "double grafted tumor system", proposed to find effector cells in the analyses of antitumor effect of BRMs.
Topics: Animals; Antibodies; Antineoplastic Agents; Cells, Cultured; Complement System Proteins; Fibrosarcoma; Immunization, Passive; Immunologic Factors; Interferon Type I; Male; Mice; Mice, Inbred BALB C; Mitomycin; Mitomycins; Neoplasm Transplantation; Phenotype; Picibanil; Polysaccharides; Spleen; Zinostatin | 1989 |
[Combination therapy of hyperthermia and other methods in liver and bile tract cancers--evaluation of these methods using cancer cell lines in vitro].
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line; Combined Modality Therapy; Doxorubicin; Fluorouracil; Gallbladder Neoplasms; Humans; Hyperthermia, Induced; In Vitro Techniques; Liver Neoplasms; Mitomycin; Mitomycins; Picibanil; Tumor Necrosis Factor-alpha | 1989 |
Augmentation of the generation of OK-432 activated killer cells after a single dose of mitomycin C in cancer patients.
Topics: Biological Products; Humans; In Vitro Techniques; Injections, Intravenous; Killer Cells, Natural; Leukocytes, Mononuclear; Lymphocytes; Mitomycin; Mitomycins; Neoplasms; Picibanil; T-Lymphocytes, Helper-Inducer; T-Lymphocytes, Regulatory | 1988 |
[A case of abdominal wall fistula due to cholangioma].
Topics: Abdominal Muscles; Adenoma, Bile Duct; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Combined Modality Therapy; Female; Fistula; Fluorouracil; Humans; Infusions, Intra-Arterial; Middle Aged; Mitomycin; Mitomycins; Picibanil; Prognosis | 1985 |
[Chemoembolization therapy of liver cancer combined with lipiodol and OK-432 intra-arterial administration].
Topics: Adult; Biological Products; Carcinoma, Hepatocellular; Doxorubicin; Embolization, Therapeutic; Female; Humans; Injections, Intra-Arterial; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Picibanil | 1986 |
[A long-term survivor of primary hepatoma--a case suggesting the superiority of a multi-drug (OK-432, SPG, PSK) over mono-drug immunotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Male; Mitomycin; Mitomycins; Picibanil; Prognosis; Proteoglycans; Sizofiran | 1986 |
[A case report of patient with advanced stomach carcinoma of linitis plastica type responding to multi-immunotherapy and chemotherapy].
Topics: Adenocarcinoma, Scirrhous; Adult; Antineoplastic Combined Chemotherapy Protocols; Biological Products; Carbazilquinone; Glycosaminoglycans; Humans; Male; Mitomycin; Mitomycins; Picibanil; Proteoglycans; Sizofiran; Stomach Neoplasms | 1987 |
[Treatment of gastric cancer based on the pathological and biophysiological aspects of cancer].
Topics: Combined Modality Therapy; Gastrectomy; Humans; Lymph Node Excision; Lymphatic Metastasis; Mitomycin; Mitomycins; Neoplasm Invasiveness; Neoplastic Cells, Circulating; Picibanil; Prognosis; Stomach; Stomach Neoplasms | 1986 |
[Surgery and adjuvant therapy of cancer of the large intestine].
Topics: BCG Vaccine; Colonic Neoplasms; Combined Modality Therapy; Doxorubicin; Drug Administration Schedule; Fluorouracil; Humans; Intraoperative Period; Mitomycin; Mitomycins; Picibanil; Postoperative Period; Proteoglycans; Radiotherapy Dosage; Rectal Neoplasms | 1986 |
[Antineoplastic effects of carnosine and beta-alanine--physiological considerations of its antineoplastic effects].
Topics: Alanine; Animals; Antineoplastic Agents; beta-Alanine; Carnosine; Dipeptides; Male; Mice; Mitomycin; Mitomycins; Picibanil; Sarcoma 180 | 1986 |
[Improved quality of life in a patient with Borrmann type 4 gastric cancer treated with combination chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Mitomycin; Mitomycins; Picibanil; Prognosis; Quality of Life; Stomach Neoplasms; Tegafur; Uracil | 1987 |
[Evaluation of a combination of UFT, MMC, and OK-432 for advanced gastro-intestinal cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Female; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Picibanil; Tegafur; Uracil | 1987 |
Antitumor activity of combination therapy with traditional Chinese medicine and OK432 or MMC.
Topics: Animals; Carcinoma, Ehrlich Tumor; Combined Modality Therapy; Immunotherapy; Liver; Medicine, Chinese Traditional; Mice; Mice, Inbred BALB C; Mitomycin; Mitomycins; Organ Size; Picibanil; Plants, Medicinal; Spleen; Tumor Necrosis Factor-alpha | 1988 |
[Effect of intra-thoracic administration of an immune modulator (OK-432) with anti-cancer drugs (ADR and MMC)].
Topics: Adjuvants, Immunologic; Aged; Antineoplastic Combined Chemotherapy Protocols; Biological Products; Doxorubicin; Female; Fever; Humans; Injections; Leukopenia; Mitomycin; Mitomycins; Neoplasms; Picibanil; Pleurisy; Prognosis; Thorax | 1988 |
[MQF-FT and MQF-UFT in gallbladder and bile duct cancer].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Carbazilquinone; Drug Administration Schedule; Female; Fluorouracil; Gallbladder Neoplasms; Humans; Infusions, Intravenous; Male; Middle Aged; Mitomycin; Mitomycins; Picibanil; Tegafur; Uracil | 1988 |
[Clinical studies of the treatment of bladder tumor and its effects--experience in 86 cases].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Combined Modality Therapy; Doxorubicin; Female; Fluorouracil; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Picibanil; Prognosis; Tegafur; Uracil; Urinary Bladder Neoplasms | 1988 |
[Preoperative combination therapy involving local administration of a non-specific immunoactivated preparation (OK-432) and chemotherapeutic preparations for patients with stomach cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biological Products; Female; Fluorouracil; Humans; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Mitomycins; Picibanil; Preoperative Care; Stomach Neoplasms | 1985 |
[Preoperative cancer chemotherapy for gastric cancer].
Topics: Administration, Oral; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Fluorouracil; Humans; Infusions, Intra-Arterial; Infusions, Parenteral; Lymphatic Metastasis; Methotrexate; Mitomycin; Mitomycins; Picibanil; Preoperative Care; Stomach Neoplasms | 1985 |
[Effective postoperative chemotherapy of gastric cancer associated with disseminated carcinomatosis of the bone marrow].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; Bone Marrow; Bone Neoplasms; Cisplatin; Combined Modality Therapy; Doxorubicin; Female; Gastrectomy; Humans; Infusions, Intra-Arterial; Lymph Node Excision; Lymphatic Metastasis; Mitomycin; Mitomycins; Pancreatectomy; Picibanil; Proteoglycans; Radionuclide Imaging; Splenectomy; Stomach Neoplasms; Tegafur | 1985 |
Immunological basis and immunotherapy of nasopharyngeal carcinoma.
Topics: Adult; Antibodies, Monoclonal; Biological Products; Cell Line; Humans; Immunity, Cellular; Interleukin-2; Killer Cells, Natural; Lymphocyte Activation; Male; Middle Aged; Mitomycin; Mitomycins; Nasopharyngeal Neoplasms; Picibanil; T-Lymphocytes, Cytotoxic | 1985 |
Immunochemosurgery for gastric cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Biological Products; Combined Modality Therapy; Cytarabine; Fluorouracil; Gastrectomy; Humans; Immunocompetence; Mitomycin; Mitomycins; Neoplasm Staging; Picibanil; Prognosis; Stomach Neoplasms | 1985 |
[Role of oral administration of 1-hexyl-carbamoyl-5-fluorouracil (HCFU) for multimodal treatment of inoperable cirrhotics with hepatocellular carcinoma].
Topics: Administration, Oral; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Fluorouracil; Hepatic Artery; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Picibanil; Prognosis | 1984 |
[Chemotherapy of urothelial cancer with vincristine, mitomycin C, bleomycin, tegafur and OK-432].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Picibanil; Tegafur; Ureteral Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms; Vincristine | 1984 |
Interferon-alpha in serum and carcinomatous pleural effusion after repeated intrapleural injections of antitumor agents.
Topics: Adenocarcinoma; Aged; Biological Products; Carcinoma, Small Cell; Drug Therapy, Combination; Female; Humans; Injections; Interferon Type I; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Picibanil; Pleura; Pleural Effusion | 1983 |
[Nonspecific cell-mediated immunity of gynecologic cancer patients and related effects of chemotherapy and immunotherapy].
Topics: Female; Fluorouracil; Humans; Immunity, Cellular; Leukocyte Count; Mitomycin; Mitomycins; Ovarian Neoplasms; Picibanil; Rosette Formation; T-Lymphocytes; Uterine Neoplasms | 1983 |
[Experimental study on active specific immunotherapy utilizing the immune reaction of low-dose irradiated tumor tissue. 9. Effect of the mitomycin C-treated, cryopreserved immune reaction combined with biological response modifier, OK-432].
Topics: Animals; Biological Products; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Mitomycin; Mitomycins; Neoplasm Transplantation; Picibanil | 1983 |
Lysis of fresh human tumor cells by autologous peripheral blood lymphocytes and pleural effusion lymphocytes activated by OK432.
Topics: Adenocarcinoma; Adult; Aged; Biological Products; Cytotoxicity, Immunologic; Dactinomycin; Female; Humans; Killer Cells, Natural; Leukemia; Lung Neoplasms; Lymphocyte Activation; Lymphocytes; Male; Middle Aged; Mitomycin; Mitomycins; Picibanil; Pleural Effusion | 1983 |
[Evaluation of chemotherapy for resected stomach cancer: second-look operation].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Female; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Picibanil; Proteoglycans; Reoperation; Stomach Neoplasms | 1983 |
[Short-term intensive chemotherapy (STIC) combined with intravenous hyperalimentation in advanced stomach cancer].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Parenteral Nutrition; Parenteral Nutrition, Total; Picibanil; Stomach Neoplasms; Tegafur | 1983 |
[Chemotherapy of unresectable Borrmann's type IV stomach cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Fluorouracil; Humans; Mitomycin; Mitomycins; Picibanil; Stomach Neoplasms; Tegafur | 1983 |
[Preoperative immunochemotherapy for gastric cancer combined with perifocal administration of OK-432].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biological Products; Female; Fluorouracil; Humans; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Mitomycins; Picibanil; Preoperative Care; Stomach Neoplasms | 1984 |
[Chemotherapy of unresectable Borrmann type 4 gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Combinations; Fluorouracil; Humans; Mitomycin; Mitomycins; Nimustine; Nitrosourea Compounds; Picibanil; Proteoglycans; Stomach Neoplasms; Tegafur; Uracil | 1984 |
[MQF-OK therapy in advanced terminal stomach cancer--with special reference to a comparison with MFC therapy].
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Cytarabine; Drug Therapy, Combination; Female; Fluorouracil; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Picibanil; Stomach Neoplasms | 1982 |
[Case of malignant melanoma of the external genitalia responding satisfactorily to a combination of local injection of OK-432 and chemotherapy].
Topics: Adjuvants, Immunologic; Antineoplastic Agents; Biological Products; Cyclophosphamide; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Injections; Melanoma; Middle Aged; Mitomycin; Mitomycins; Picibanil; Vincristine; Vulvar Neoplasms | 1982 |
[Pre-operative chemotherapy of stomach cancer combined with local administration of OK-432--evaluation of macroscopic results].
Topics: Aged; Animals; Antibiotics, Antineoplastic; Biological Products; Carcinoma, Ehrlich Tumor; Drug Therapy, Combination; Female; Fluorouracil; Humans; Injections; Male; Mice; Middle Aged; Mitomycin; Mitomycins; Picibanil; Preoperative Care; Stomach Neoplasms | 1982 |
[Preoperative OMF therapy for gastric cancer--examination of macroscopical effect in comparison with histological effect].
Topics: Adult; Aged; Biological Products; Drug Therapy, Combination; Female; Fluorouracil; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Picibanil; Preoperative Care; Stomach; Stomach Neoplasms | 1982 |
Curative treatments of murine Colon26 solid tumors by immunochemotherapy with G-CSF and OK-432.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Colonic Neoplasms; Cyclophosphamide; Cytotoxicity, Immunologic; Epirubicin; Female; Granulocyte Colony-Stimulating Factor; Immunologic Factors; Macrophages; Mice; Mice, Inbred BALB C; Mitomycin; Neoplasm Proteins; Picibanil; Recombinant Proteins; Tumor Cells, Cultured | 1995 |
[Two cases of hepatic metastasis of colorectal cancer treated effectively by intrahepatic arterial infusion immunotherapy using OK-432, rIL-2, MMC and 5-FU].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Administration Schedule; Female; Fluorouracil; Humans; Immunotherapy; Infusions, Intra-Arterial; Interleukin-2; Liver Neoplasms; Male; Middle Aged; Mitomycin; Picibanil; Recombinant Proteins | 1994 |
[Complete response in a case of unresectable gastric cancer treated by combined chemoimmunotherapy of MMC, 5-FU and OK-432].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Humans; Mitomycin; Picibanil; Remission Induction; Stomach Neoplasms | 1994 |
[A case of advanced gastric cancer with liver and lung metastasis effectively treated by combined chemo-immunotherapy of MMC, 5'-DFUR, OK-432].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Administration Schedule; Floxuridine; Humans; Immunotherapy; Liver Neoplasms; Lung Neoplasms; Male; Mitomycin; Picibanil; Stomach Neoplasms | 1993 |
[Immunological effects of locoregional immunochemotherapy for liver metastases of gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cytokines; Doxorubicin; Fluorouracil; Humans; Immunotherapy; Injections, Intralesional; Interleukin-2; Killer Cells, Natural; Liver Neoplasms; Mitomycin; Picibanil; Stomach Neoplasms | 1993 |
Differential chemosensitivity of local and metastatic human gastric cancer after orthotopic transplantation of histologically intact tumor tissue in nude mice.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Count; Combined Modality Therapy; Disease Models, Animal; Drug Screening Assays, Antitumor; Fluorouracil; Humans; Immunotherapy; Killer Cells, Natural; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Mitomycin; Neoplasm Transplantation; Picibanil; Spleen; Stomach Neoplasms; Transplantation, Heterologous | 1993 |
KRN7000, a novel immunomodulator, and its antitumor activities.
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents; Female; Galactosylceramides; Immunologic Factors; Killer Cells, Natural; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred Strains; Mitomycin; Picibanil; Poly I-C; Stimulation, Chemical | 1995 |
[Effect of intraperitoneal therapy in gastric cancer with peritoneal dissemination].
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Cisplatin; Female; Humans; Immunity, Cellular; Immunotherapy; Infusions, Parenteral; Male; Middle Aged; Mitomycin; Peritonitis; Picibanil; Stomach Neoplasms; Survival Rate | 1997 |
[Effects of OK-432 intraportal administration on cell-mediated immune responses].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Humans; Immunity, Cellular; Immunologic Factors; Immunotherapy; Infusions, Parenteral; Killer Cells, Natural; Liver Neoplasms; Lymphocyte Subsets; Mitomycin; Picibanil | 1997 |
Unresectable advanced gastric cancer effectively treated by combined chemo-immunotherapy: a report of two cases.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Fluorouracil; Humans; Immunotherapy; Male; Mitomycin; Picibanil; Radiography; Stomach Neoplasms | 2000 |
Evaluation of intraoperative intraperitoneal cytology for advanced gastric carcinoma.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Signet Ring Cell; Combined Modality Therapy; Female; Gastrectomy; Humans; Intraoperative Care; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Peritoneal Cavity; Peritoneal Neoplasms; Picibanil; Postoperative Care; Stomach Neoplasms; Survival Rate | 2002 |
Expression of multidrug resistance-associated protein1,P-glycoprotein, and thymidylate synthase in gastric cancer patients treated with 5-fluorouracil and doxorubicin-based adjuvant chemotherapy after curative resection.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Fluorouracil; Gastrectomy; Humans; Immunotherapy; Lentinan; Life Tables; Male; Middle Aged; Mitomycin; Neoplasm Proteins; Picibanil; Stomach Neoplasms; Survival Analysis; Thymidylate Synthase | 2002 |
[Experimental study in the effects of transarterial immuno-chemoembolization in hepatocellular carcinoma].
Topics: Animals; Antibiotics, Antineoplastic; Chemoembolization, Therapeutic; Combined Modality Therapy; Immunotherapy; Interleukin-2; Iodized Oil; Liver Neoplasms, Experimental; Male; Mitomycin; Picibanil; Rats; Rats, Inbred ACI; Tumor Necrosis Factor-alpha | 2005 |
[Case report--postoperative continuous intraarterial infusion of small doses of 5-FU successfully controlled residual tumor and liver metastasis of stage IV gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Doxorubicin; Drug Combinations; Floxuridine; Fluorouracil; Gastrectomy; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Methotrexate; Mitomycin; Neoplasm Staging; Picibanil; Proteoglycans; Stomach Neoplasms; Tegafur; Uracil | 2005 |
[A case of carcinomatous cardiac tamponade due to breast cancer treated with OK-432 and mitomycin C].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Cardiac Tamponade; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Mitomycin; Pericardial Effusion; Pericardiocentesis; Picibanil; Quality of Life | 2007 |
[A case of carcinomatous cardiac tamponade caused by breast cancer treated with instillations of OK-432 and mitomycin C].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cardiac Tamponade; Drainage; Female; Humans; Mitomycin; Picibanil; Radiography | 2010 |